Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!
ATS 2022 Conference
- Home
- Ats Conference 2022
Oral Treprostinil: FREEDOM
FREEDOM-EV, a global, event-driven trial which established that 3 times daily (TID) TRE delayed disease progression when added to oral monotherapy replaced parenteral treprostinil in carefully selected patients.
Our Recent Articles
Types / Technology
Indications
Title
Is Trelegy Ellipta more efficacious than other COPD therapies?
Summary
GSK presents a comparative efficacy study of Fluticasone/Umeclidinium/Vilanterol (FF/UMEC/VI) versus other triple therapies
Article Type
Drug Analysis
Title
Triple vs. dual therapy for the management of COPD
Summary
Triple therapy appears to reduce the number of relapses and improve the quality of life over double therapy in patients with COPD.
Article Type
Drug Analysis
Title
An evolving Treatment Paradigm
Summary
The future treatment patterns of PAH address the unmet needs and improve patient outcomes
Article Type
Clinical Trials
Title
Future of Pulmonary Rehabilitation
Summary
The non-pharmacological outpatient program is employed in chronic respiratory patients, mainly COPD, as a part of standard management and health maintenance
Article Type
Non-Pharmacological
Title
MRx-4DP0004- a next-generation drug for management
Summary
MRx-4DP0004 is a lyophilised formulation of the Bifidobacterium breve strain of commensal bacteria which is a live biotherapeutic derived from the microbiota of a healthy human infant.
Article Type
Clinical Trials
Title
Riociguat potential benefit
Summary
Bayer`s Riociguat is in clinical developement for patients with pulmonary arterial hypertension (PAH) and persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH).
Article Type
Drug Analysis
Case Studies
Partner Identification
Partners Identification for client's early-stage oncology-based clinical product for late-stage clinical development & commercialization.
Pipeline Assessment
Assessment of pipeline activities around the client's area of interest to support strategic decisions.
Epidemiology Assessment
In-depth assessment to understand the epidemiological scenario of Cutaneous Squamous Cell Carcinoma
Market Assessment
Evaluation of the oncological market potential of the asset gained through the acquisition and collaborations
Product Assessment
Performance evaluation of new assets based on the Lead and Lag KPI
Newsletter and Whitepapers
Gout Market is Anticipated to Expand Due to Active as well as Emerging Pipeline Therapies
Gout is a chronic disease caused by the deposition of monosodium urate (MSU) crystals in joints. It typically presents as an acute, self-limiting inflammatory monoarthritis that affects the joints of the lower limb. Various symptoms of Gout include intense joint pain, joint swelling, stiffness, tenderness, even to light touch, such as from a bedsheet, heat in the affected area, and joint redness.
Get Expert Consultation Now!
Our long standing experience and rich expertise in the respiratory domain can be a perfect partner for your pressing business problems
Our in-depth knowledge of the respiratory pipeline, granular understanding of market dynamics and acute perception of marketing nuances can help you create a highly successful plan for future performance.
Get in touch with us to discuss potential partnership and to know more about what we can offer you.
Delivering value through our expansive service offerings
Taking into account the highly dynamic landscape of respiratory therapy area, it is of utmost importance to attain competitive edge early on in your business. With our repository of consulting solutions and market research offerings, we are well-positioned to advise you on how to navigate the barriers as well as leverage your strengths and opportunities.
We impart insights aimed at leveraging competitive advantage and formulating effective business growth strategies. Journey with us to realize opportunities as well as pitfalls, as we make it easier for you to capitalize your return on investment through our expert advice.
Involve us to help you collect insights on which asset could hold the most potential in the future.
Our 10-year forecast provides foresight for effective strategy-building for successful market entry
Our research expertise delivers real-time information that elevates your business decisions
We assist in navigating the tricky drug development terrain by providing intelligence assessments